Clinical pharmacology in the adolescent oncology patient.
about
Enhancing Adolescent and Young Adult Oncology Research Within the National Clinical Trials Network: Rationale, Progress, and Emerging StrategiesHow I treat acute lymphoblastic leukemia in older adolescents and young adultsPatterns of chemotherapy-induced toxicities in younger children and adolescents with rhabdomyosarcoma: a report from the Children's Oncology Group Soft Tissue Sarcoma CommitteeEffect of age and body weight on toxicity and survival in pediatric acute myeloid leukemia: results from NOPHO-AML 2004.Long-term hospitalisation rates among 5-year survivors of Hodgkin lymphoma in adolescence or young adulthood: A nationwide cohort studyThreading the cloak: palliative care education for care providers of adolescents and young adults with cancerDifferences in outcomes of newly diagnosed acute myeloid leukemia for adolescent/young adult and younger patients: a report from the Children's Oncology Group.Analysis of outcomes in adolescents and young adults with chronic myelogenous leukemia treated with upfront tyrosine kinase inhibitor therapy.Ontogeny and sorafenib metabolism.Symptom Interval and Patient Delay Affect Survival Outcomes in Adolescent Cancer PatientsPatient Characteristics and Outcomes in Adolescents and Young Adults (AYA) With Acute Myeloid Leukemia (AML).The adolescent and young adult with cancer: state of the art-- acute leukemias.Intra-patient dose escalation in Ewing's sarcoma treated with vincristine, doxorubicin, cyclophosphamide alternating with ifosfamide and etoposide: a retrospective review.Adult rhabdomyosarcoma survival improved with treatment on multimodality protocols.The challenge of access to care for soft tissue sarcomas bridging pediatric and adult age: the Italian pediatric oncology view.Enrolling Adolescents in Disease/Target-Appropriate Adult Oncology Clinical Trials of Investigational Agents.Nationwide Statistical Analysis of Lymphoid Malignancies in Korea.Teenagers and young adults with cancer in Europe: from national programmes to a European integrated coordinated project.Pediatric clinical pharmacology: an introduction to a series of educational papers.Joint adolescent-adult early phase clinical trials to improve access to new drugs for adolescents with cancer: proposals from the multi-stakeholder platform-ACCELERATE.Patient characteristics and outcomes in adolescents and young adults with classical Philadelphia chromosome-negative myeloproliferative neoplasms.Health care experiences of long-term survivors of adolescent and young adult cancer.ENCCA WP17-WP7 consensus paper on teenagers and young adults (TYA) with bone sarcomas
P2860
Q28086955-FD4C4003-54BB-46DA-9FE7-4828E33ED228Q28087589-C31C8484-766A-400D-B97A-B9E8CADC6971Q33396263-B19354AD-C880-4686-A2FC-F1D88BCE1506Q33573539-55A493B1-66A1-44BD-816F-0A2F7CDBD410Q33578319-BCC307E5-838B-469C-9086-48BEB3BC1F85Q35148951-0B18FEA4-FDC7-4F67-BED2-85D75F5EEB8DQ35430146-3C460CA4-675E-4748-A65D-7056565CBBA1Q36094702-EC3B68E4-8E4D-429E-97A8-91680E02EA07Q36375706-29E163C8-42CE-414B-B620-2AE846B45B5CQ36707868-087D8251-08C4-4240-AE26-8BA6817D1ABAQ36739522-33385067-B6F0-474D-932A-DFEA6F1EA4DEQ37134753-C7934B51-8BE9-4423-9316-25311BB3E710Q37400113-E9AF1EDC-4616-41DC-A134-880D96C456C6Q37591136-E6893E88-2D72-4AFB-91EA-81EB035AF6FBQ37982451-221182D1-553F-4D24-A41A-CBC554FADAD6Q38990759-C80A44A2-22BB-42DD-8E60-FF66AD976676Q40265830-215766F5-07BB-412C-B9F3-B8A1F8A57EDAQ41517323-30722264-43EC-4534-A179-F80C76987A56Q44185876-18A84788-80DF-441A-8F42-EE3F3DD796DAQ48530699-DDA54F9F-D39B-4295-941C-A4F7877994F3Q49978793-DCBF7DCB-36CA-4239-88FD-3FFA05F9ABB2Q53111914-3636C7E4-173E-4E28-AEBE-46B2E99378B2Q56973339-EB6E9A70-4062-4537-95B6-A25A4878E0C1
P2860
Clinical pharmacology in the adolescent oncology patient.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Clinical pharmacology in the adolescent oncology patient.
@ast
Clinical pharmacology in the adolescent oncology patient.
@en
type
label
Clinical pharmacology in the adolescent oncology patient.
@ast
Clinical pharmacology in the adolescent oncology patient.
@en
prefLabel
Clinical pharmacology in the adolescent oncology patient.
@ast
Clinical pharmacology in the adolescent oncology patient.
@en
P2860
P921
P356
P1476
Clinical pharmacology in the adolescent oncology patient.
@en
P2093
Christine M Hartford
Clinton F Stewart
P2860
P304
P356
10.1200/JCO.2010.28.3473
P407
P577
2010-05-03T00:00:00Z